Log In
person
Adaptive Biotechnologies Corp
ADPT
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Sequencing |
Genetic, Genomic, and Sequencing Services for Life Science Research
These companies provide genetic, genomic, and sequencing services for life science research.
|
170.28M | 100.00% |
| Sequencing |
Pre-Revenue Infectious Disease Vaccines
These companies research and develop vaccines for infectious diseases, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Sequencing
Genetic, Genomic, and Sequencing Services for Life Science Research
|
170.28M | 100.00% |
| keyboard_arrow_right |
These companies provide genetic, genomic, and sequencing services for life science research.
|
||
| keyboard_arrow_down |
Sequencing
Pre-Revenue Infectious Disease Vaccines
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop vaccines for infectious diseases, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||